Michael Carulli - Mar 3, 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Financial Officer
Signature
/s/ Robert Ticktin, by power of attoreny
Stock symbol
PMVP
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/5/2025, 06:34 PM
Previous filing
Sep 12, 2024
Next filing
Jul 3, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Award $0 +265K $0.00 265K Mar 3, 2025 Common Stock 265K $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.